Effect of immunotherapy and spleen preservation on immunological function in patients with gastric cancer

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 3, 2006, Pages 339-349

  Okinaga, Kota ^a   Iinuma, H ^a   Kitamura, Y ^a   Yokohata, T ^a   Inaba, T ^a   Fukushima, R ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Immunological function; Immunotherapy; NK activity; Spleen preservation

Indexed keywords

INTERLEUKIN 2; MITOMYCIN C; PICIBANIL; UFT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOTHERAPY; MALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE CARE; PRESERVATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPLEEN EXAMINATION; STOMACH CANCER; SURGICAL TECHNIQUE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PICIBANIL; PROSPECTIVE STUDIES; SPLEEN; SPLENECTOMY; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 33751102396     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dicken B.J., Bigam D. L., Cass C., Mackey J. R., Joy A. A., Hamilton S. M.: Gastric adenocarcinoma. Review and considerations for future directions. Ann. Surg. 241:27-39, 2005
2. Wanebo H.J., Kennedy B.J., Winchester D.P., et al.: Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on long term survival. J. Am. Coll. Surg. 185:177-1845, 1997.
3. Yoshino K., Yamada Y., Asanuma F., et al.: Splenectomy in cancer gastrectomy: recommendation of spleen-preserving for early stages. Int. Surg. 82:150-154, 1997.
4. Csendes A.: A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric cancer. Surgery 131:401-407, 2002.
5. Erturk S.: Effect of simultaneous splenectomy on the survival of patients undergoing curative gastrectomy for proximal gastric carcinoma. Surg. Today 33:254-258, 2003.
6. Kim J.P., Kwon O.J., Oh S.T., et al.: Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann. Surg. 216:269-279, 1992
7. Tumor Marker Committee for the Study Group of Immunotherapy with PSK for Gastric Cancer: Saji S., Sakamoto J., Teramukai S., et al: Impact of splenectomy and immunotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Surg. Today. 29:504-510, 1999
8. Toge T., Kameda A., Yamada H., et al.: Role of spleen on immunosuppression in esophageal and gastric cancer. Jpn. J. Surg. 16:330-335, 1986.
9. Okuno K., Tanaka A., Shigeoka H., et al.: Immunological assessment of thespleen in patients with gastric cancer. Asian J. Surg. 19:225-231, 1996.
10. Noma K., Yamaguchi Y., Okita R., Matsuura K., Toge T: The spleen plays an Immunosuppressive role in patients with gastric cancer: Involvement of CD62L+ and TGF-beta. Anticancer Res. 25:643-650, 2005
11. Japanese Gastric Cancer Association: Japanese classification of gastric cancer: First English edition, Tokyo, KANEHARA & CO. LTD, 1995
12. Japanese Gastric Cancer Association: A guideline for treatment of gastric cancer. Second edition. Tokyo, KANEHARA & CO. LTD, 2004
13. Sheeley J. K., Golub S. H.: Studies on cytotoxicity generalized in human mixed lymphocyte cultures. ?. Time course and target spectrum of severe distinct concomitant cytotoxic activities. J. Immunol. 120:1415-1422, 1978
14. Toge T., Hamamoto A., Yamada H., et al: Concanavalin A-induced and spontaneous suppressor cell activities in peripheral blood lymphocytes and spleen cells from gastric cancer patients. Cancer 52:1624-1631, 1983
15. Takahashi M., Fujimoto S., Takai M.: Two-color flow cytometric analysis of splenic lymphocyte subpopulations in patients with gastric cancer. Jpn. J. Surg. 22:35-39, 1992.
16. Akiyoshi T., Koba F., Arinaga S., et al.: Cell-mediated cytoxic activity of spleen cells from patients with gastric carcinoma. Jpn. J. Surg. 18:164-171, 1988.
17. O'Garra A. Vieira P.: Regulatory T cell and mechanism of immune system control. Nat. Med. 10:801-805, 2004
18. Miwa H, Kojima K, Ono F, et al. Effect of splenectomy and immunotherapy on advanced gastric cancer associated with total gastrectomy. Jpn. J. Surg. 13:20-24, 1983,
19. Suehiro S., Nagasue N., Ogawa Y., et al.: The negative effect of splenectomy on the prognosis of gastric cancer. Am. J. Surg. 148:645-648, 1984.
20. Brady M.S., Rogatko A., Dent L.L., et al.: Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch. Surg. 126:359-364, 1991.
21. . Adachi Y., Kamakura T., Mori M., et al: Role of lymph node dissection and splenectomy in node-positive gastric carcinoma. Surgery 116:837-841, 1994
22. Yoshino K., Asanuma K., Haruyama F. et al: Evaluation of splenectomy for possible metastasis from gastric cancer, with reference to nonspecific immunological parameters and post-operative survival. J. Jpn. Surg. Soc. 83: 947-951, 1983
23. Tamada K., Harada M., Abe K. at al: Antitumor vaccination effect of dendritic cells can be augumented by locally utilizing Th-1 type cytokines from OK-432-reactive CD+T cell. Cancer Immunol. Immunother. 46:128-136, 1998
24. Estape J., Grau J.J., Lcobendas F., et al.: Mitomycin C as an adjuvant treatment to resected gastric cancer. Ann. Surg. 213:219-221, 1991.
25. Maehara Y., Okuyama T., Kakeji Y., et al.: Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion. Am. J. Surg. 168:36-40, 1994.